# This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC

> **NCT07723924** · PHASE2 · RECRUITING · sponsor: **Bausch Health Americas, Inc.** · enrollment: 180 (estimated)

## Conditions studied

- Functional Constipation (FC)

## Interventions

- **DRUG:** plecanatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07723924
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-18
- **Primary completion:** 2027-10-18
- **Final completion:** 2027-10-18
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07723924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07723924, "This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07723924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*